Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
09/2003
09/04/2003US20030166963 Using tertiary amine catalyst
09/04/2003US20030166808 Addition polymers; absorbers; molding materials
09/04/2003US20030166717 Substituted amide compound containing hydroxy and amino groups; useful for treating Alzheimer's disease and other similar diseases
09/04/2003US20030166690 Use of compounds for decreasing activity of hormone-sensitive
09/04/2003US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
09/04/2003US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/04/2003US20030166622 Vitamin D derivatives with acyloxy groups in the side chains, process for their production, and the use for the production of pharmaceutical agents
09/04/2003US20030166619 N2O2- functionality is bound direct to a carbon atom; treating biological disorders hypertension, restenosis, impotency, genetic disorders or infections
09/04/2003US20030166506 Method of producing n-[(2S)-sulfanyl-4-(1,5,5-trimethylhydantoinyl)butanoyl]-L-leucyl-L-tert-leucine N-methylamide and intermediate thereof
09/04/2003US20030165623 Copper deposition using copper formate complexes
09/04/2003CA2477607A1 Substituted hydroxyethylamines
09/03/2003EP1340744A2 Hiv protease inhibitors
09/03/2003EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands
09/03/2003EP1339695A1 Farnesyltransferase inhibitors
09/03/2003EP1339694A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists
09/03/2003EP1339684A1 Mch antagonists and their use in the treatment of obesity
09/03/2003EP1339663A2 Naphthalene derivatives
09/03/2003EP1339400A1 Hydroxamic acid or n-formyl hydroxylamine derivatives as inhibitors of bacterial polypeptide deformylase for treating microbial infections
09/03/2003EP0839139B1 Hydrophobic ionic liquids
09/03/2003EP0775689B1 Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic
09/03/2003EP0744435B1 Water-absorbent resin, process for production thereof, and water-absorbent resin composition
09/03/2003CN1440412A Thienopyrrolidinones
09/03/2003CN1440396A Colchinol derivatives as angiogenesis inhibitors
09/03/2003CN1120158C Process for preparation of formylimidazoles
09/03/2003CN1119988C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition
09/03/2003CN1119987C Composition for oxidation dyeing of keratin fibres and dyeing process using this composition
09/02/2003US6613920 25-(5-propylimidazol-2-yl)-26,27-cyclo-9, 10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; antagonizes the action of calcitriol in HL 60 cells; hyperprolifierative diseases of the skin, tumor diseases and precancerous stages
09/02/2003US6613789 Heterocyclo-substituted imidazoles for the treatment of inflammation
09/02/2003US6613783 Non-systemic control of parasites
09/02/2003US6613771 Prevent human retroviral reproduction, infections
08/2003
08/28/2003WO2003070735A2 Components for producing amphoteric liposomes
08/28/2003WO2003070220A1 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same
08/28/2003WO2003016285A8 Method of preparing 4-(imidazole-1-il)benzenesulphonamide derivatives
08/28/2003US20030162974 Synthesis of oxygen-substituted benzocycloheptenes as valuable intermediate products for the production of tissue-selective estrogens
08/28/2003US20030162967 Having antithrombotic effect; fortherapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses; reversible inhibitors of blood clotting enzymes factor Xa and/or factor VIIa
08/28/2003US20030162965 Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds
08/28/2003US20030162823 Novel C-4 substituted retinoids
08/28/2003US20030162822 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine and the use thereof as a drug
08/28/2003US20030162786 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein
08/28/2003US20030162778 Carbocyclic side chain containing metalloprotease inhibitors
08/28/2003US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
08/27/2003EP1337516A1 Process for manufacture of imidazoles
08/27/2003EP1337511A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity
08/27/2003EP1337504A2 Novel polyamine analog-amino acid conjugates useful as anticancer agents
08/27/2003EP1337247A1 Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity
08/27/2003EP1337218A2 Substituted felbamate derived compounds
08/27/2003EP1195375B1 Benzamide derivatives, insecticides for agricultural and horticultural use and usage thereof
08/27/2003EP1165547B1 Substituted benzoylpyrazoles as herbicides
08/27/2003EP0644760B1 Use of imidazole for the treatment of diseases characterized by neovascularization
08/27/2003CN1438990A Aminoacid-iodine complex
08/27/2003CN1438899A Ethylenedicysteine (EC)-drug conjugates
08/27/2003CN1119148C Use of alpha 1L agonists in treatment of in continence
08/26/2003US6610882 Affinity for bradykinin receptors; antithrombotics
08/26/2003US6610846 Heteroaromatic glucokinase activators
08/26/2003US6610734 Heterocyclic sulfonamide inhibitors of beta amyloid production
08/26/2003US6610731 Antiinflammatory
08/26/2003US6610729 Hydroxamic acid derivatives and medicinal utilization thereof
08/26/2003US6610723 Imidazole derivatives
08/26/2003US6610716 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
08/26/2003US6610715 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
08/26/2003US6610710 Inflammatory bowel diseases, diabetes, tumor proliferation and tumor metastasis.
08/26/2003US6610664 Cationic lipids
08/26/2003US6610269 Disease state imaged using a targeted contrast agent of the formula V-L-R, where V is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker, R is a macromolecular or particulate label
08/21/2003WO2003069350A2 Small molecule modulators of apoptosis
08/21/2003WO2003068758A1 Optically active azole derivative and process for producing the same
08/21/2003WO2003068755A1 Novel tricycloimidazoline derivatives, method for production and use thereof as medicaments
08/21/2003WO2003068224A2 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
08/21/2003WO2003020217A3 Novel pyrazole analogs acting on cannabinoid receptors
08/21/2003WO2002036162A3 Compositions for treatment of ocular neovascularization and neural injury
08/21/2003WO2002032844A8 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives
08/21/2003WO2002002512A3 Compounds to treat alzheimer's disease
08/21/2003US20030158420 Bladder urogenital disorders
08/21/2003US20030158418 Novel imidazonline compounds
08/21/2003US20030158256 (Arylaminoaceamido)acetonitrile derivatives
08/21/2003US20030158185 Novel use of phenylheteroakylamine derivatives
08/21/2003US20030158180 Antidepressants; treating anxiety, stress, eating disorders, bipolar disorder, drug abuse and drug dependence, schizophrenic disorders, psychotic disorders, cognitive activators, obesity, emesis, rheumatoid arthritis, cancer
08/21/2003CA2476454A1 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
08/21/2003CA2475880A1 Novel tricycloimidazoline derivatives, method for production and use thereof as medicaments
08/20/2003EP1336603A1 Method of introducing amino group and method of synthesizing amino acid
08/20/2003EP1335988A2 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
08/20/2003EP1335901A1 Pharmaceutically active sulfanilide derivatives
08/20/2003EP0923542B1 Aryl substituted cyclic amines as selective dopamine d3 ligands
08/20/2003CN1437578A (P-amino-hyaroxyphenyl)-acrylamide derivatives and dyes containing said compounds
08/20/2003CN1118467C 1,3,8-triaza-spiro [4,5] decan-4-on derivatives
08/20/2003CN1118457C Cyclic diamine compound and medicine containing the same
08/19/2003US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity
08/19/2003US6608196 Structurally diverse; parallel approach
08/19/2003US6608099 Indole sPLA2 inhibitors
08/19/2003US6608095 Sulfonylbenzene and sulfonamidobenzene compounds which inhibit COX-2; treatment of a medical condition in which prostaglandins are implicated as pathogens
08/19/2003US6608093 Polyarylpyrazole or polyarylpyrole or polyaryltriazole compounds or intermediates for pesticides
08/19/2003US6608061 Bisaryl compound and medicament for cancer treatment comprising the same
08/14/2003WO2003066889A2 Assay for acytyltransferase or deacetylase activity
08/14/2003WO2003066600A1 Processes for preparing imidazole derivatives and salts thereof
08/14/2003WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
08/14/2003WO2003066035A2 Compounds for inhibiting insulin secretion and methods related thereto
08/14/2003WO2003065789A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
08/14/2003WO2003024955A3 Small molecule inhibitors of caspases
08/14/2003WO2003000662A3 Chiral preparation of a diastereomeric compound
08/14/2003US20030153801 Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease
08/14/2003US20030153769 Reacting a 3-halotetrahydrofuran or tetrahydropyran compound with formamidine or its salt in the presence of a base to produce a 3-(1H-imidazol-4-yl)propanol derivative; efficiency; intermediates; anticarcinogenic agents; viricides;
1 ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 ... 345